Press Reviews

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique. Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat. Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Business Cann

SynBiotic SE & Enchilada Group: Joint Venture To Launch First Cannabis Store In Germany

April 22, 2022

Read Article

Cannalist

CannaList Conversations with Lars Müller, CEO of SynBiotic SE

January 15, 2022

Read Article

Entrepreneur

Lars Mueller Explains How SynBiotic Uses The Power of Cannabinoids To Heal Modern World Diseases

December 6, 2021

Read Article

Washinton Latest

SynBiotic SE: Most important cannabis merger in Europe

December 2, 2021

Read Article

Hemp Today

€11 million deal combines German groups, creating a hemp powerhouse in Europe

December 1, 2021

Read Article

Cannalist.eu

Important Cannabis Merger in Europe – Daniel Kruse Joins Forces with SynBiotic SE

December 1, 2021

Read Article

businesscann.com

German Cannabis Company Continues Its Strong Growth – A Further Seven Million Euros For SynBiotic SE

October 27, 2021

Read Article

International Business Times

How CBPlus Will Revolutionize The Global Cannabinoid Market

October 22, 2021

Read Article

Yahoo Finance

German Platform Company On The Brink Of Revolutionizing Cannabinoid Market

July 26, 2021

Read Article

Benzinga

SynBiotic SE Becomes The First Publicly Traded Company In Germany To Hedge Against…

February 16, 2021

Read Article

Yahoo Finance

Beyond Cannabis: How This German Company Is Disrupting The Cannabis Market

December 29, 2020

Read Article

More News

Newsroom

In full bloom: WEECO Pharma boosts SYNBIOTIC's sales

Read More
Corporate

Share price target 12.50 euros: Annual General Meeting supports SYNBIOTIC's growth plans with over 99 percent approval

Read More
Corporate

1.6 million euros for Hanf Farm: Federal Ministry for Economic Affairs and Climate Protection funds bio-economy project

Read More
Corporate
All Corporate News

SynBiotic SE: Begebung einer Wandelanleihe von bis zu EUR 300.000,00 unter Ausschluss des Bezugsrechts beschlossen.

Ad Hoc
Read More

SynBiotic SE erwartet deutliches Umsatzwachstum für das Geschäftsjahr 2024

Ad Hoc
Read More

SynBiotic SE schließt Einbringungsvertrag über den Erwerb aller Anteile an der WEECO Pharma GmbH, Hildesheim ab

Ad Hoc
Read More
All ad Hoc Releases
HomeAbout UsVenturesTeamNewsroomContactInvestor Relation
© 2024 SYNBIOTIC SE. All rights reserved.
Privacy PolicyImprint